Desk›Fast Moving Consumer Goods› Indrayani Biotech Ltd
Indrayani Biotech Ltd
BSE 526445 · NSE INDRANIB · ISIN INE007C01021 · Group X · Active
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Agricultural Food & other Products › Other Agricultural Products
₹7.98
+0.50%
BSE close, 28 August 2026
₹62.29 cr
7.8 cr shares · Micro cap
₹41.36 cr
as published
-12.5× · 0.67×
EPS ₹-0.64 · BV ₹11.91
21.90 / 0.70
₹ cr, as filed
17
5 selected · 29%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -51.5% |
|---|---|
| Against 52-week low | +30.8% |
| Day change | +0.50% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.64 |
|---|---|
| Price / earnings | -12.47× |
| Price / book | 0.67× |
| Book value — derived, price ÷ P/B | ₹11.91 |
| Return on equity | -5.39% |
| Operating margin | -19.22% |
| Net margin | -88.11% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -5.37%
- ROE as published
- -5.39%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Mar-26 · Q | 4.08 | -3.60 | 0.01 | -19.22% | -88.11% |
| Dec-25 · Q | 5.20 | 0.08 | 0.01 | 25.80% | 1.54% |
| FY25-26 | 21.90 | 0.70 | 0.15 | 26.46% | 3.20% |
Quarter on quarter
- Revenue, quarter on quarter
- -21.5%
- Net profit, quarter on quarter
- -4,600.0%
- Operating margin, quarter on quarter
- -4,502 bps
Disclosure profile 17 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Results | 2 |
| KMP | 1 |
| Selected sub-total | 5 |
| Procedural | |
| General | 5 |
| Board Meeting | 2 |
| Newspaper Publication | 2 |
| Compliance Certificate | 1 |
| Rights / Bonds | 1 |
| Trading Window | 1 |
| Procedural sub-total | 12 |
| Total | 17 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
17 filings · 5 selected · busiest 2026-09-09 and 2026-10-07
Filing rhythm · the twelve most recent
2026-09-072026-10-07
SelectedProcedural
Filings
17 in the window · 6 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulation 2018, for the quarter ended 30th September 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
7 October 2026 ·
Results-Unaudited Standalone & Consolidated Financial Results For Quarter Ended June 30, 2026 Along With Limited Review Report.
Unaudited Standalone & Consolidated Financial Results for quarter ended June 30, 2026 along with Limited Review Report.
Result / Financial Results View filing →
-
7 October 2026 ·
Board Meeting Outcome for Board Meeting Outcome For Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30Th June 2026 Along With Limited Review Report.
Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30th June 2026 Along With Limited Review Report.
Board Meeting / Outcome of Board Meeting View filing →
-
30 September 2026 ·
Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015
Indrayani Biotech Limited has informed the Sale of Shares of Subsidiary Company under Regulation 30 of SEBI LODR 2015
Company Update / General View filing →
-
30 September 2026 ·
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Intimation For Board Meeting To Be Held On 7Th October, 2026
Indrayani Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....
Board Meeting / Board Meeting View filing →
-
29 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window for the Quarter and Half year Ending 30th September, 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
15 September 2026 ·
Newspaper Publication
News Paper Publication as per Regulation 84 of SEBI(Issue of Capital and Disclosure Requirements), 2018 with respect to Rights Issue.
Company Update / Newspaper Publication View filing →
-
9 September 2026 ·
Letter Of Offer For Rights Issue
Letter of Offer for Rights Issue
Company Update / General View filing →
-
9 September 2026 ·
Corporate Action-Outcome of Right issue
Outcome of the Rights Issue Committee held 09th September,2026.
Corp. Action / Bonds / Right issue View filing →
-
9 September 2026 ·
Appointment of Company Secretary and Compliance Officer
Appointment of Mr. C.S. Shanmuga Sundar, as a company secretary and compliance officer of the company. W.e.f. 09th September, 2026.
Company Update / Appointment of Company Secretary / Compliance Officer View filing →
-
7 September 2026 ·
Resignation Of Secretarial Auditor.
Resignation of Mr. K. Ravichandran as the Secretarial Auditor of the Company.
Company Update / General View filing →
-
7 September 2026 ·
Extension Of Time Granted For Holding The AGM For FY 2025-26
Approval received for AGM Extension (FY 2025-26)
Company Update / General View filing →
-
20 August 2026 ·
Newspaper Publication
News paper Publication of audited financials results (Standalone & Consolidated) for quarter and year ended March 31, 2026.
Company Update / Newspaper Publication View filing →
-
19 August 2026 ·
Result-Audited Financial Results For Quarter And Year Ended March 31, 2026 Along With Report Of Statutory Auditor.
Audited financial results for quarter and year ended March 31, 2026 along with report of statutory auditors.
Company Update / General View filing →
-
17 August 2026 ·
Board Meeting Outcome for Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended 31St March 2026 Along With Report Of Statutory Auditors.
Audited Standalone & consolidated financial results for the quarter and year ended 31st March 2026 along with report of statutory auditors.
Board Meeting / Outcome of Board Meeting View filing →
-
17 August 2026 ·
Results-Delay in Financial Results
Audited Standalone & Consolidated financial results for the quarter and year ended March 31, 2026 along with auditors report.
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Intimation for Board Meeting Intimation For Intimation For Board Meeting To Be Held On 17Th August, 2026
Indrayani Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Indrayani Biotech Ltd has ....
Board Meeting / Board Meeting View filing →
RSS feed for Indrayani Biotech Ltd · the 50 most recent filings